The FDA has proposed taking pediatric ingestible fluoride supplement drug products off the market - a decision that would eliminate access to fluoride tablets and drops used to prevent tooth decay in children without adequate fluoride in their drinking water. These products are clinically supported and vital for vulnerable children, yet the FDA is acting on inconclusive evidence and public pressure to eliminate them. The ADA is submitting official comments and strongly urges all members of the profession to speak out.
Here’s how you can help:
We need the profession to act now—before these fluoride supplements are lost to regulatory overreach.